Tab. II.
Antimicrobial profiles of MRSA (HA-MRSA and CA-MRSA) and MSSA isolates from 100 patients of Kerman University affiliated hospitals.
| Type of isolates | Rate of resistance to antimicrobial agents. n(%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Isolates. n(%) | AK | GM | CD | E | CIP | T | SXT | |
| CA-MRSA | 14 (14%) | 3 (6.8) | 6 (13.6) | 9 (13.6) | 14 (31.8) | 6 (13.6) | 11(25) | 6 (13.6) |
| HA-MRSA | 30 (30%) | 21 (47.7) | 25(57) | 20 (45.5) | 27 (61.4) | 25(57) | 27 (61.4) | 15 (34.1) |
| MSSA | 56 (56%) | 1 (1.8) | 2 (3.6) | 2 (3.6) | 11 (19.6) | 8 (14.3) | 16 (28.6) | 17 (30.4) |
| Total | 100(100) | 25(25) | 33(33) | 31(31) | 52(52) | 39(39) | 54(54) | 38(38) |
AK; Amikacin, GM; Gentamicin, CD; Clindamycin, E; Erythromycin, CIP; Ciprofloxacin, T; Tetracycline, SXT; trimethoprim/sulfamethoxazole,